Avalon Pharma renews SAR 54.2M credit facilities deal with SAIB

25/08/2025 Argaam
The credit facility is aimed at financing the company's working capital and assets financing

The credit facility is aimed at financing the company's working capital and assets financing

Middle East Pharmaceutical Industries Co. (Avalon Pharma) renewed a Shariah-compliant credit facility agreement with The Saudi Investment Bank (SAIB) worth SAR 54.23 million.

 

In a statement to Tadawul, the company said that the one-year credit facility is aimed to finance its working capital and assets financing.

 

For more news on listed companies

 

It added that the facility is guaranteed by a promissory note to the total facility value of SAR 54.23 million.

 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.